财务摘要（报告期）（Soleno Therapeutics Inc）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 每股指标： | ||||||||
| 每股收益EPS基本(元) | -2.36 | -2.65 | -1.69 | -0.88 | -2.87 | -2.60 | -0.12 | -0.07 |
| 每股净资产(元) | 4.97 | 1.50 | 1.25 | 0.32 | 1.27 | 1.86 | 0.17 | 0.22 |
| 每股经营现金净流量(元) | -0.79 | -1.20 | -1.24 | -0.82 | -2.55 | -1.92 | -0.09 | -0.05 |
| 每股现金流量净额(元) | 4.90 | 2.45 | 0.48 | -0.82 | -0.82 | -0.19 | 0.02 | 0.06 |
| 盈利能力： | ||||||||
| 净资产收益率平均(%) | -46.45 | -164.99 | -147.81 | -128.68 | -171.05 | -112.64 | -65.35 | -25.87 |
| 总资产净利率(%) | -37.64 | -61.51 | -58.60 | -36.31 | -77.57 | -55.03 | -34.38 | -14.66 |
| 投入资本回报率ROIC(%) | -340.43 | -240.74 | -143.42 | -70.95 | -184.11 | -140.36 | -92.06 | -41.15 |
| 收益质量： | ||||||||
| 营业利润／利润总额(%) | 106.15 | 99.21 | 101.55 | 101.35 | 101.37 | 101.11 | 100.83 | 100.86 |
| 资本结构： | ||||||||
| 资产负债率(%) | 12.83 | 63.46 | 59.84 | 86.49 | 60.95 | 52.47 | 44.91 | 37.81 |
| 权益乘数 | 1.15 | 2.74 | 2.49 | 7.40 | 2.56 | 2.10 | 1.82 | 1.61 |
| 产权比率 | 0.15 | 1.74 | 1.49 | 6.40 | 1.56 | 1.10 | 0.82 | 0.61 |
| 流动资产／总资产(%) | 94.83 | 84.44 | 66.24 | 46.72 | 59.05 | 64.33 | 67.52 | 70.46 |
| 非流动资产／总资产(%) | 5.17 | 15.56 | 33.76 | 53.28 | 40.95 | 35.67 | 32.48 | 29.54 |
| 流动负债／负债合计(%) | 49.62 | 71.89 | 47.51 | 45.93 | 45.28 | 43.76 | 43.77 | 45.46 |
| 非流动负债／负债合计(%) | 50.38 | 28.11 | 52.49 | 54.07 | 54.72 | 56.24 | 56.23 | 54.54 |
| 归属母公司股东的权益／投入资本(%) | 1,430.58 | 208.98 | 107.34 | 22.63 | 86.99 | 124.30 | 158.71 | 194.97 |
| 偿债能力： | ||||||||
| 流动比率 | 14.89 | 1.85 | 2.33 | 1.18 | 2.14 | 2.80 | 3.43 | 4.10 |
| 速动比率 | 14.89 | 1.85 | 2.33 | 1.18 | 2.14 | 2.80 | 3.43 | 4.10 |
| 货币资金／流动负债(%) | 1,474.85 | 180.86 | 220.14 | 101.46 | 199.67 | 269.01 | 332.11 | 396.20 |
| 营业利润／流动负债(%) | -359.70 | -94.76 | -194.27 | -109.12 | -333.61 | -255.88 | -173.23 | -78.94 |
| 经营活动产生的现金流量净额／流动负债(%) | -216.78 | -64.24 | -139.74 | -86.69 | -284.17 | -212.99 | -151.56 | -87.00 |
| 归属母公司股东的权益／负债合计(%) | 679.38 | 57.58 | 67.10 | 15.62 | 64.08 | 90.59 | 122.68 | 164.51 |
| 经营活动产生的现金流量净额／负债合计(%) | -107.57 | -46.19 | -66.39 | -39.82 | -128.68 | -93.20 | -66.34 | -39.55 |
| 营业利润／负债合计(%) | -178.50 | -68.13 | -92.30 | -50.12 | -151.07 | -111.97 | -75.83 | -35.89 |
| 成长能力： | ||||||||
| 总资产同比增长率(%) | 581.93 | 98.72 | -16.05 | -54.08 | -25.47 | - | -24.43 | -24.97 |
| 每股净资产同比增长率(%) | 292.05 | -19.41 | 639.14 | 46.27 | 469.25 | - | -50.84 | -53.13 |
| 总负债同比增长率(%) | 43.56 | 140.35 | 11.87 | 5.04 | -9.07 | - | -22.44 | -15.95 |
| 基本每股收益同比增长率(%) | 17.77 | -14.72 | - | 17.76 | 50.60 | 50.76 | 52.00 | 36.36 |
| 归属母公司股东的权益同比增长率(%) | 1,422.10 | 52.76 | -38.81 | -90.03 | -41.84 | - | -25.98 | -29.57 |
| 营业利润同比增长率(%) | -69.63 | -46.24 | -36.17 | -46.70 | 22.62 | 34.14 | 37.99 | 36.95 |
| 股东权益合计同比增长率(%) | 1,422.10 | 52.76 | -38.81 | -90.03 | -41.84 | - | -25.98 | -29.57 |
| 营运能力： | ||||||||
| 衍生指标： | ||||||||
| 现金及现金等价物净增加额TTM(元) | 155,079,000.00 | 32,686,000.00 | -4,697,000.00 | -21,100,000.00 | -6,702,000.00 | -8,434,000.00 | -9,531,000.00 | -12,633,000.00 |
| 利润总额TTM(元) | -38,988,000.00 | -33,178,000.00 | -28,449,000.00 | -26,699,000.00 | -24,067,000.00 | -21,409,000.00 | -23,417,000.00 | -27,680,000.00 |
| 投入资本(元) | 11,010,000.00 | 11,111,000.00 | 11,576,000.00 | 11,661,000.00 | 11,895,000.00 | 12,228,000.00 | 12,796,000.00 | 13,572,000.00 |
| 经营活动产生的现金流量净额TTM(元) | -24,940,000.00 | -23,769,000.00 | -22,093,000.00 | -21,147,000.00 | -20,781,000.00 | -22,501,000.00 | -23,251,000.00 | -26,644,000.00 |
| 归属母公司净利润TTM(元) | -38,988,000.00 | -33,178,000.00 | -28,449,000.00 | -26,699,000.00 | -24,067,000.00 | -21,409,000.00 | -23,417,000.00 | -27,680,000.00 |